Market
Health & bioClear all
Lanes are never summed. Equity is Form D filings and matched press rounds; awards and exits will have their own sources.
Health & bio: subsectors
6 subsectors, sized by amount sold · 90 days to 2026-10-04 · as of 2026-10-0416 rounds not yet in a sector
16 rounds not yet in a sector
- ▲ Rising
- Steady
- Leaning (80%)
- ▼ Falling
- Quiet
Coloured by subsector state, 28 days to 2026-10-03 vs prior 28; shaded when the change is clear at 90% confidence, palest when only at 80%.
Equity · amount sold
Capital by week
Dollars sold per filing week, round count under each bar · 4 weeks to 2026-10-04 · as of 2026-10-04Stage mix
Inferred stage · 90 days to 2026-10-04 · as of 2026-10-04- Pre-seed123 roundsPre-seed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $157MAmount sold in original Pre-seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Seed383 roundsSeed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.2BAmount sold in original Seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series A287 roundsSeries A rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.7BAmount sold in original Series A filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series B88 roundsSeries B rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.5BAmount sold in original Series B filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series C+84 roundsSeries C+ rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $28.8BAmount sold in original Series C+ filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Stage not inferred7 roundsStage not inferred rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.0BAmount sold in original Stage not inferred filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
Bar length is each stage’s share of the window’s rounds. Dollars of original filings only: an amendment’s restated amount counts in the map, not here. Stage is inferred from the amount sold, never stated on Form D; a stage named in a press release wins.
Where it landed
Which states the money was raised from, by the company's HQ · 90 days to 2026-10-04 · as of 2026-10-04- $0+
- $353M+
- $1.4B+
- $3.2B+
- $5.7B+
Mega-rounds shown separately (see the band above)
Rounds
Newest first · every row traces to a Form D on EDGAR or a matched press release · as of 2026-10-04| Company | Sector | Stage | Sold of offered | Filed | HQ | Exemption | Open roles | Hiring | Flags | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sinopia BiosciencesHiring actively$2.8M of $4.3M · Seed · Health & bio · 506(b) · San Diego, CA · 2026-07-16 | Sinopia Biosciences | Health & bio | Seed | $2.8M of $4.3MAmount sold of the amount offered on the filing of 2026-07-16 · as of 2026-10-04How this is computed → | 2026-07-16 | San Diego, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Lynch Regenerative MedicineQuiet$15.0M of $17.5M · Series A · Health & bio · 506(b) · Franklin, TN · 2026-07-15 | Lynch Regenerative Medicine | Health & bio | Series A | $15.0M of $17.5MAmount sold of the amount offered on the filing of 2026-07-15 · as of 2026-10-04How this is computed → | 2026-07-15 | Franklin, TN | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| 410 MedicalQuiet$10.3M of $12.0M · Series A · Health & bio · 506(b) · Durham, NC · 2026-07-15 | 410 Medical | Health & bio | Series A | $10.3M of $12.0MAmount sold of the amount offered on the filing of 2026-07-15 · as of 2026-10-04How this is computed → | 2026-07-15 | Durham, NC | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Dash BioQuiet$30.0M of $30.0M · Series B · Health & bio · 506(b) · Boston, MA · 2026-07-14 | Dash Bio | Health & bio | Series B | $30.0M of $30.0MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | Boston, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| ImmunoVecHiring actively$12.7M of $15.0M · Series A · Health & bio · 506(b) · Los Angeles, CA · 2026-07-14 | ImmunoVec | Health & bio | Series A | $12.7M of $15.0MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | Los Angeles, CA | 506(b) | 3The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| WesperQuiet$8.3M of $8.3M · Series A · Health & bio · 506(b) · New York, NY · 2026-07-14 | Wesper | Health & bio | Series A | $8.3M of $8.3MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | New York, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Wesper: $9.6M of $9.6M · Series A · Health & bio · 506(b) · New York, NY · 2026-07-14 | Wesper | Health & bio | Series A | $9.6M of $9.6MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | New York, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Neurofold Therapeutics Inc.Quiet$6.5M of $6.5M · Series A · Health & bio · 506(b) · Greenwood Village, CO · 2026-07-14 | Neurofold Therapeutics Inc. | Health & bio | Series A | $6.5M of $6.5MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | Greenwood Village, CO | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Laxmi Therapeutic DevicesHiring actively$2.1M of $2.1M · Seed · Health & bio · 506(b) · Goleta, CA · 2026-07-14 | Laxmi Therapeutic Devices | Health & bio | Seed | $2.1M of $2.1MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | Goleta, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Reticle Biosystems, Inc.Quiet$1.0M of $1.0M · Pre-seed · Health & bio · 506(b) · San Francisco, CA · 2026-07-14 | Reticle Biosystems, Inc. | Health & bio | Pre-seed | $1.0M of $1.0MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | San Francisco, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| PluristyxQuiet$9.8M of $14.8M · Series A · Health & bio · 506(b) · Seattle, WA · 2026-07-13 | Pluristyx | Health & bio | Series A | $9.8M of $14.8MAmount sold of the amount offered on the filing of 2026-07-13 · as of 2026-10-04How this is computed → | 2026-07-13 | Seattle, WA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Procode AIQuiet$9.5M of $10.0M · Series A · Health & bio · 506(b) · Los Angeles, CA · 2026-07-13AI-native | Procode AIAI-native | Health & bio | Series A | $9.5M of $10.0MAmount sold of the amount offered on the filing of 2026-07-13 · as of 2026-10-04How this is computed → | 2026-07-13 | Los Angeles, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| InnSight TechnologyQuiet$1.4M of $3.0M · Pre-seed · Health & bio · 506(b) · Pittsburgh, PA · 2026-07-13Undersubscribed | InnSight TechnologyUndersubscribed | Health & bio | Pre-seed | $1.4M of $3.0MAmount sold of the amount offered on the filing of 2026-07-13 · as of 2026-10-04How this is computed → | 2026-07-13 | Pittsburgh, PA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | Undersubscribed |
| Vantis VascularQuiet$18.6M of $21.5M · Series A · Health & bio · 506(b) · San Jose, CA · 2026-07-10 | Vantis Vascular | Health & bio | Series A | $18.6M of $21.5MAmount sold of the amount offered on the filing of 2026-07-10 · as of 2026-10-04How this is computed → | 2026-07-10 | San Jose, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Yuvo HealthHiring actively$4.3M of $5.0M · Seed · Health & bio · 506(b) · New York, NY · 2026-07-10 | Yuvo Health | Health & bio | Seed | $4.3M of $5.0MAmount sold of the amount offered on the filing of 2026-07-10 · as of 2026-10-04How this is computed → | 2026-07-10 | New York, NY | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| CeleCor TherapeuticsQuiet$11.9M of $15.0M · Series A · Health & bio · 506(b) · Del Mar, CA · 2026-07-09 | CeleCor Therapeutics | Health & bio | Series A | $11.9M of $15.0MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Del Mar, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AmlogenyxQuiet$10.0M of $20.0M · Series A · Health & bio · 506(b) · Novato, CA · 2026-07-09 | Amlogenyx | Health & bio | Series A | $10.0M of $20.0MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Novato, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Akadeum Life SciencesQuiet$2.1M of $3.4M · Seed · Health & bio · 506(b) · Ann Arbor, MI · 2026-07-09 | Akadeum Life Sciences | Health & bio | Seed | $2.1M of $3.4MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Ann Arbor, MI | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Skybound MedtechQuiet$1.3M of $1.3M · Pre-seed · Health & bio · 506(b) · Houston, TX · 2026-07-09 | Skybound Medtech | Health & bio | Pre-seed | $1.3M of $1.3MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Houston, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Hyperion SurgicalQuiet$13.2M of $23.7M · Series A · Health & bio · 506(b) · Weston, FL · 2026-07-08AI-native | Hyperion SurgicalAI-native | Health & bio | Series A | $13.2M of $23.7MAmount sold of the amount offered on the filing of 2026-07-08 · as of 2026-10-04How this is computed → | 2026-07-08 | Weston, FL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| AllswellHiring actively$6.8M of $8.3M · Series A · Health & bio · 506(b) · San Francisco, CA · 2026-07-08 | Allswell | Health & bio | Series A | $6.8M of $8.3MAmount sold of the amount offered on the filing of 2026-07-08 · as of 2026-10-04How this is computed → | 2026-07-08 | San Francisco, CA | 506(b) | 16The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| CarePredictQuiet$2.0M of $10.0M · Seed · Health & bio · 506(b) · Plantation, FL · 2026-07-07AI-nativeUndersubscribed | CarePredictAI-nativeUndersubscribed | Health & bio | Seed | $2.0M of $10.0MAmount sold of the amount offered on the filing of 2026-07-07 · as of 2026-10-04How this is computed → | 2026-07-07 | Plantation, FL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-nativeUndersubscribed |